BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37270804)

  • 21. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
    Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
    J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian small cell carcinoma in one of a pair of monozygous twins.
    Fahiminiya S; Sabbaghian N; Albrecht S; Nadaf J; Callegaro-Filho D; Foulkes WD
    Fam Cancer; 2019 Apr; 18(2):161-163. PubMed ID: 30284660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Driver Mutations in Rare Cancers: The Role of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT).
    Lang JD; Hendricks WPD
    Methods Mol Biol; 2018; 1706():367-379. PubMed ID: 29423809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type.
    David MP; Venkatramani R; Lopez-Terrada DH; Roy A; Patil N; Fisher KE
    Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30275002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour.
    Foulkes WD; Clarke BA; Hasselblatt M; Majewski J; Albrecht S; McCluggage WG
    J Pathol; 2014 Jul; 233(3):209-14. PubMed ID: 24752781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2:
    Chan-Penebre E; Armstrong K; Drew A; Grassian AR; Feldman I; Knutson SK; Kuplast-Barr K; Roche M; Campbell J; Ho P; Copeland RA; Chesworth R; Smith JJ; Keilhack H; Ribich SA
    Mol Cancer Ther; 2017 May; 16(5):850-860. PubMed ID: 28292935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix.
    Tandon B; Hagemann IS; Maluf HM; Pfeifer JD; Al-Kateb H
    Int J Gynecol Pathol; 2017 Nov; 36(6):593-599. PubMed ID: 28177947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.
    Jelinic P; Schlappe BA; Conlon N; Tseng J; Olvera N; Dao F; Mueller JJ; Hussein Y; Soslow RA; Levine DA
    Mod Pathol; 2016 Jan; 29(1):60-6. PubMed ID: 26564006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics.
    Clarke BA; Witkowski L; Ton Nu TN; Shaw PA; Gilks CB; Huntsman D; Karnezis AN; Sebire N; Lamovec J; Roth LM; Stewart CJ; Hasselblatt M; Foulkes WD; McCluggage WG
    Histopathology; 2016 Nov; 69(5):727-738. PubMed ID: 27100627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Comprehensive management of a newly diagnosed young adult.
    Pressey JG; Dandoy CE; Pater LE; Sroga Rios J; Sisson R; Dasgupta R; Szabo S
    Gynecol Oncol; 2020 Sep; 158(3):538-546. PubMed ID: 32654763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
    Wang Y; Chen SY; Colborne S; Lambert G; Shin CY; Santos ND; Orlando KA; Lang JD; Hendricks WPD; Bally MB; Karnezis AN; Hass R; Underhill TM; Morin GB; Trent JM; Weissman BE; Huntsman DG
    Mol Cancer Ther; 2018 Dec; 17(12):2767-2779. PubMed ID: 30232145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases.
    Callegaro-Filho D; Gershenson DM; Nick AM; Munsell MF; Ramirez PT; Eifel PJ; Euscher ED; Marques RM; Nicolau SM; Schmeler KM
    Gynecol Oncol; 2016 Jan; 140(1):53-7. PubMed ID: 26546963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade.
    Jelinic P; Ricca J; Van Oudenhove E; Olvera N; Merghoub T; Levine DA; Zamarin D
    J Natl Cancer Inst; 2018 Jul; 110(7):787-790. PubMed ID: 29365144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small Cell Carcinoma of Ovary, Hypercalcemic Type (Malignant Rhabdoid Tumor of Ovary) with Loss of SMARCA4 (BRG1) Expression: Report of Two Cases.
    Sahay A; Kante K; Menon S; Ghosh J; Kerkar RA; Deodhar KK
    Turk Patoloji Derg; 2020; 1(1):261-267. PubMed ID: 32149361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
    Agaimy A; Thiel F; Hartmann A; Fukunaga M
    Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary.
    Jelinic P; Mueller JJ; Olvera N; Dao F; Scott SN; Shah R; Gao J; Schultz N; Gonen M; Soslow RA; Berger MF; Levine DA
    Nat Genet; 2014 May; 46(5):424-6. PubMed ID: 24658004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small Cell Carcinoma of the Ovary, Hypercalcemic Type, in a 12-Month-Old Girl.
    Atwi D; Quinton MR; Kiser RM; Pokala HR; Rooms LM; Yu Z
    Pediatr Dev Pathol; 2021; 24(5):493-497. PubMed ID: 34047234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
    Zheng L; Zhang L; Wang XI; Katz G; Tandon N; Zhao B; Lucci J; Ding J; Zhang S
    Hum Pathol; 2022 Jun; 124():45-55. PubMed ID: 35331811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
    Andrianteranagna M; Cyrta J; Masliah-Planchon J; Nemes K; Corsia A; Leruste A; Holdhof D; Kordes U; Orbach D; Corradini N; Entz-Werle N; Pierron G; Castex MP; Brouchet A; Weingertner N; Ranchère D; Fréneaux P; Delattre O; Bush J; Leary A; Frühwald MC; Schüller U; Servant N; Bourdeaut F
    J Pathol; 2021 Sep; 255(1):1-15. PubMed ID: 33999421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small Cell Carcinoma of Ovary, Hypercalcemic Type: Cytologic, Histopathologic, and Immunohistochemical Landscapes of a Rare Case.
    Aggarwal D; Gupta P; Chhabra P; Peters NJ; Bansal D; Srinivasan R; Kakkar N
    J Pediatr Adolesc Gynecol; 2021 Feb; 34(1):98-102. PubMed ID: 32750414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.